Roche, CH0012032048

Roche Holding - Weekly review and pharma sector comparison

19.06.2026 - 14:45:23 | ad-hoc-news.de

Roche Holding remains a key heavyweight on the Swiss market. With no major new corporate announcements this week, investors are looking at the stock’s recent performance, sector backdrop and upcoming catalysts in the global pharmaceuticals space.

Roche, CH0012032048
Roche, CH0012032048

Edited by ad hoc news Sector & Peer-Group Desk. Verified prior to publication on 06/19/2026, 14:44 CET. Details in the imprint.

Roche Holding (CH0012032048) remains one of the most closely watched healthcare names on the Swiss market. With no fresh ad-hoc releases or major analyst rating changes this week, investors are primarily assessing its recent trading performance and how it stacks up against other large pharmaceutical groups.

Go deeper

All news and key data on Roche Holding stock

Background information, historical news and further price data help put the current weekly picture of Roche Holding into perspective.

How Roche Holding shares fared this week

Roche Holding shares trade on the SIX Swiss Exchange under the ticker ROG, with the non-voting equity security often serving as the main liquidity line for international investors according to the exchange data.

On Friday, Roche Holding’s registered shares were quoted around CHF 319.00 in Zurich, implying a modest decline on the day and leaving the stock slightly lower over the past five trading sessions compared with the broader Swiss market.

Position in the global pharma peer group

With a market capitalization in the tens of billions of Swiss francs, Roche Holding ranks among the largest European pharmaceutical manufacturers and sits in the same global peer group as Novartis, Sanofi and AstraZeneca.

In sector terms, large-cap pharma and biotechnology stocks have recently seen mixed performance as investors balance defensive earnings profiles with uncertainties around drug pricing and patent expiries.

What the company sells

Roche Holding generates most of its revenue from prescription medicines in oncology, immunology, hemophilia and neuroscience, while its diagnostics division supplies instruments and tests for clinical labs and hospitals around the world.

Where the stock trades today

The shares of Roche Holding (CH0012032048) trade on the SIX Swiss Exchange at CHF 319.00 as of 06/19/2026, 14:44 CET.

Key facts on Roche Holding stock

  • Company: Roche Holding AG
  • ISIN: CH0012032048
  • WKN: 855167
  • Ticker: ROG
  • Venue: SIX Swiss Exchange
  • Price (as of 06/19/2026, 14:44 CET): 319.00 CHF
  • Market cap: 219,000,000,000 CHF (as of 06/19/2026)
  • Sector / Industry: Health Care / Pharmaceuticals & Biotechnology
  • Index membership: SMI, Stoxx Europe 50
  • Next earnings date: not officially scheduled

More on Roche Holding stock on social media

This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.

en | CH0012032048 | ROCHE | boerse | 69582637 | bgmi